In 1998, it was listed as a schedule 2 substance under ROC drug abuse prevention regulations, and as a schedule 2 controlled substance under the law governing pharmaceuticals. Taiwan does not allow its use for medical purposes.
民國八十七年國內將之列為「毒品危害防制條例」第二級毒品，及「管制藥品管理條例」第二級管制藥品，在台灣並無合法醫療用途。